Difference between revisions of "LncRNAWiki:Lymphoma"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Name !width="50"|Transcript ID !width="50"|Alias !width="50"|Description !width="50"|Disease |-...") |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 48: | Line 48: | ||
|leukemia-associated non-coding IGF1R activator RNA 1 | |leukemia-associated non-coding IGF1R activator RNA 1 | ||
|lymphoma | |lymphoma | ||
| + | |- | ||
| + | |''CD44-AS1'' | ||
| + | |[[CD44-AS1]] | ||
| + | |RP1-68D18.4 | ||
| + | |CD44 antisense RNA 1 | ||
| + | |B cell lymphoma | ||
| + | |- | ||
| + | |''LILRB1-AS1'' | ||
| + | |[[LILRB1-AS1]] | ||
| + | |AC009892.10 | ||
| + | |LILRB1 antisense RNA 1 | ||
| + | |B cell lymphoma | ||
| + | |- | ||
| + | |''LINC02238'' | ||
| + | |[[LINC02238]] | ||
| + | |RP4-788P17.1 | ||
| + | |long intergenic non-protein coding RNA 2238 | ||
| + | |B cell lymphoma | ||
| + | |- | ||
| + | |''MEF2C-AS2'' | ||
| + | |[[MEF2C-AS2]] | ||
| + | |CTC-467M3.1 | ||
| + | |MEF2C antisense RNA 2 | ||
| + | |B cell lymphoma | ||
| + | |- | ||
| + | |''MIR4422HG'' | ||
| + | |[[MIR4422HG]] | ||
| + | |RP11-101C11.1 | ||
| + | |MIR4422 host gene | ||
| + | |B cell lymphoma | ||
| + | |- | ||
| + | |''SPON1-AS1'' | ||
| + | |[[SPON1-AS1]] | ||
| + | |RP11-21, L19.1 | ||
| + | |SPON1 antisense RNA 1 | ||
| + | |B cell lymphoma | ||
|} | |} | ||
Latest revision as of 07:20, 28 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| GAS5 | NONHSAT007663 | SNHG2, ENSG00000234741 | _ | autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus |
| PVT1 | ENST00000513868.2 | NCRNA00079, LINC00079, onco-lncRNA-100 | Pvt1 oncogene (non-protein coding) | breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer |
| TCL6 | TCL6 | TCL6e1, TNG2, TNG1 | T-cell leukemia/lymphoma 6 (non-protein coding) | leukemia, lymphoma |
| SNHG5 | NONHSAT054526 | U50HG, ENSG00000203875 | Small nucleolar RNA host gene 5 | lymphoma |
| MIR17HG | MIR17HG | FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048 | miR-17-92a-1 cluster host gene | lymphoma, syndromic developmental defect |
| MINCR | ENST00000517411.1 | TCONSN/A00015189 | MYC-induced long noncoding RNA | Burkitt lymphoma |
| LUNAR1 | LUNAR1 | N/A | leukemia-associated non-coding IGF1R activator RNA 1 | lymphoma |
| CD44-AS1 | CD44-AS1 | RP1-68D18.4 | CD44 antisense RNA 1 | B cell lymphoma |
| LILRB1-AS1 | LILRB1-AS1 | AC009892.10 | LILRB1 antisense RNA 1 | B cell lymphoma |
| LINC02238 | LINC02238 | RP4-788P17.1 | long intergenic non-protein coding RNA 2238 | B cell lymphoma |
| MEF2C-AS2 | MEF2C-AS2 | CTC-467M3.1 | MEF2C antisense RNA 2 | B cell lymphoma |
| MIR4422HG | MIR4422HG | RP11-101C11.1 | MIR4422 host gene | B cell lymphoma |
| SPON1-AS1 | SPON1-AS1 | RP11-21, L19.1 | SPON1 antisense RNA 1 | B cell lymphoma |
